Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate.

The osteoinductive properties of porous titanium fiber mesh, with or without a calcium phosphate coating and loaded with recombinant human bone morphogenic protein-2 (rhBMP-2) or rhBMP-2 and native bovine BMP (S-300) were investigated in a rat ectopic assay model. A total of 112 calcium phosphate-coated and 112 noncoated porous titanium implants, either loaded with rhBMP-2 and S-300 or loaded with rhBMP-2 alone, were subcutaneously placed in 56 Wistar-King rats. The rats were killed 5, 10, 20, and 40 days postoperatively, and the implants were retrieved. Histologic analysis demonstrated that all growth factor and carrier combinations induced ectopic cartilage and bone formation at 5 and 10 days, respectively. At 20 days, bone formation increased and was characterized by trabecular bone and bone marrow-like tissue. At 40 days, more lamellar bone and hemopoietic bone marrow-like tissue were present. At both times, more bone had been formed in calcium phosphate-coated implants than in noncoated samples. Further, in rhBMP-2 and S-300-loaded specimens, bone formation was higher than in rhBMP-2 only-loaded specimens. In rhBMP-2 only-loaded specimens, bone formation was mainly localized inside the mesh material, whereas in specimens loaded with both rhBMP-2 and S-300, the bone was localized inside and surrounding the titanium mesh. The histological findings were confirmed by calcium content and alkaline phosphatase activity measurements. In addition, all specimens showed osteocalcin expression as early as 5 days postoperatively. Our results show that the combination of titanium mesh with BMPs can induce ectopic bone formation and that this bone formation seems to be similar to "enchondral" ossification. In addition, a thin calcium phosphate coating can have a beneficial effect on the bone-inducing properties of a scaffold material. Finally, rhBMP-2 and native BMP act synergistically in ectopic bone induction.

[1]  M. Murata,et al.  Carrier-dependency of cellular differentiation induced by bone morphogenetic protein in ectopic sites. , 1998, International journal of oral and maxillofacial surgery.

[2]  K. Kusumoto,et al.  Comparison of recombinant and purified human bone morphogenetic protein. , 1999, The British journal of oral & maxillofacial surgery.

[3]  C. Klein,et al.  A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. , 1988, Stain technology.

[4]  J. Jansen,et al.  Application of magnetron sputtering for producing ceramic coatings on implant materials. , 1993, Clinical oral implants research.

[5]  J. Jansen,et al.  Wound healing phenomena in titanium fibre mesh: the influence of the length of implantation. , 1997, Biomaterials.

[6]  I. Ono,et al.  A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. , 1992, Plastic and reconstructive surgery.

[7]  C. ANDREW L. BASSETT,et al.  Influence of Oxygen Concentration and Mechanical Factors on Differentiation of Connective Tissues in vitro , 1961, Nature.

[8]  J. Jansen,et al.  Bone formation in calcium-phosphate-coated titanium mesh. , 2000, Biomaterials.

[9]  H. Takita,et al.  BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo , 1993, The Anatomical record.

[10]  R. Kaufman,et al.  Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. , 1992, Growth factors.

[11]  Y. Jin,et al.  Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. , 1998, International journal of oral and maxillofacial surgery.

[12]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[13]  R. Tranquillo,et al.  Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. , 1999, Journal of biomedical materials research.

[14]  E. King,et al.  Estimation of Plasma Phosphatase by Determination of Hydrolysed Phenol with Amino-antipyrine , 1954, Journal of clinical pathology.

[15]  D. Rosen,et al.  Transforming Growth Factor-β2 Enhances the Osteoinductive Activity of a Bovine Bone-Derived Fraction Containing Bone Morphogenetic Protein-2 and 3 , 1991 .

[16]  I. Ono,et al.  Prostaglandin E1 and recombinant bone morphogenetic protein effect on strength of hydroxyapatite implants. , 1999, Journal of biomedical materials research.

[17]  H. Takita,et al.  Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. , 1997, European journal of oral sciences.

[18]  H. V. Connerty,et al.  Determination of serum calcium by means of orthocresolphthalein complexone. , 1966, American journal of clinical pathology.

[19]  T. L. Loo,et al.  Elevated inary excretion of 4-aminoimidazole-5-carboxamide in patients after intravenous injection of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide. , 1969, Life sciences.

[20]  J. Jansen,et al.  Tissue reaction to soft-tissue anchored percutaneous implants in rabbits. , 1994, Journal of biomedical materials research.

[21]  B. Hall Hypoxia and differentiation of cartilage and bone from common germinal cells in vitro. , 1969, Life sciences.

[22]  I. Takahashi,et al.  BMPs induce endochondral ossification in rats when implanted ectopically within a carrier made of fibrous glass membrane , 1997, The Anatomical record.

[23]  C. Bosch,et al.  Recombinant Transforming Growth Factor‐β1 Induces Endochondral Bone in the Baboon and Synergizes with Recombinant Osteogenic Protein‐1 (Bone Morphogenetic Protein‐7) to Initiate Rapid Bone Formation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  I. Ono,et al.  Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by prostaglandin E1. , 1996, Bone.

[25]  P. Ma,et al.  Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. , 1999, Journal of biomedical materials research.

[26]  H. Ohgushi,et al.  BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. , 1998, Journal of biomedical materials research.

[27]  A. Poole,et al.  Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. , 1995, Connective tissue research.